HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Korean Committee Recommends Bill Allowing OTC Supermarket Sales

This article was originally published in The Tan Sheet

Executive Summary

The law could go into effect as early as August to allow sales of 20 types of OTC drugs – painkillers, cold medicines, digestive products and fever reducers – beyond the traditional outlet of pharmacies.

You may also be interested in...



In Brief

FDA proposes amending ANDA-blocking petition reg; Sara Lee snaps up Tea Forté; testing by FDA, CDC find no bacteria in Enfamil formula powder; USP offers draft probiotics standards; more news In Brief.

Korea’s Expanded OTC Sales Challenge Firms’ Production And Distribution

South Korean drug firms need more time to expand their manufacturing and distribution to make some OTC products available at supermarkets and convenience stores in addition to pharmacies.

Korea's Pharmacists, Doctors Clash Over Prescription Drug Sales; Ministry Calls For Expanded Painkiller Distribution

SEOUL - What started as a simple task of widening public access to some over-the-counter drugs has now evolved into a turf war between South Korea's pharmacist and doctor associations, and the Ministry of Health And Welfare is now calling for a new round of OTC distribution revisions before the first round has finished

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124993

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel